Shopping Cart
Remove All
Your shopping cart is currently empty
Pagibaximab is a human chimeric monoclonal antibody targeting lipoteichoic acid, a surface fatty acid of Staphylococcus, for preventing Staphylococcus infections.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $619 | - | In Stock | |
| 10 mg | $1,050 | - | In Stock | |
| 25 mg | $1,550 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock |
| Description | Pagibaximab is a human chimeric monoclonal antibody targeting lipoteichoic acid, a surface fatty acid of Staphylococcus, for preventing Staphylococcus infections. |
| Synonyms | BSYX-A110, BSYX-A 110, Anti-S. Epidermidis LTA Recombinant Antibody |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | LTA |
| Molecular Weight | 146.07 (kDa) |
| Cas No. | 595566-61-3 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.